Simple Plex for COVID-19 Research

Real-Time Biological Phenotyping

When researching an acute SARS-CoV-2 infection and the resulting and deadly COVID-19 disease, speed and data quality are key. Ella enables cytokine and pro-inflammatory biomarker immunoassays in a multianalyte, automated and standardized format. Get the most reliable immunoassay results in real time with Ella.

  • After loading the cartridge, data is available in just 75 minutes, getting you to critical decision points faster
  • Factory calibrated cartridges and built-in standard curves minimize inter-lot variability allowing you to get the same measurement anywhere
  • 80% reduction in manual steps eliminates operator error and inconsistent results

Discount Pricing on Ella for COVID-19 Research

Ella is here to help in your fight against COVID-19. For researchers in this space, we're offering the fully automated platform for 25% off. If you're fighting this terrible disease, then we'd like to help!

How Ella is Helping During COVID-19

Ella is at the forefront of the fight against COVID-19. The Human Immune Monitoring Center at Mount Sinai is leveraging the high-quality data and real-time results of Ella to understand if an immunologic response during COVID-19 is turning deadly. This insight is helping them determine if novel immuno-modulating therapies have the potential to mediate response to the virus.

Watch this virtual meeting organized by the NIH and FDA, to learn more about the role of cytokines in COVID-19 and how researchers at Mount Sinai established a rapid and quantitative cytokine test on Ella to obtain actionable immune monitoring data during the management of COVID-19 patients.

Cytokines in COVID-19 Webinar

Watch Mount Sinai’s Miriam Merad, M.D., Ph.D. discuss the progress they’ve made using Ella for real-time immune profiling of the hyperinflammatory response during COVID-19 in this webinar.

COVID-19 Immune Response Profiling Webinar

Researchers at the Ichan School of Medicine at Mount Sinai publish in Nature Medicine using The Cytokine Storm Panel on Ella! Read their work, entitled, “An Inflammatory cytokine signature predicts COVID-19 severity and survival”.

Nature Medicine logo

Ella Promises Better Clinical Care for Acute Respiratory Failure and Sepsis

Immune Response to SARS-Cov-2 Researcher, Dr. Tan

"Timely results from Ella have the potential to direct treatment for acute diseases where administration needs to take place in a matter of hours."

- Michael Matthay, M.D., Ph.D., Professor of Medicine, University of California San Francisco

Characterizing T-cell Immune Responses Against SARS-CoV-2 with Ella

Immune Response to SARS-Cov-2 Researcher, Dr. Tan

"Ella is a simple and fast immunoassay platform that would be ideal for implementation in higher biosafety facilities, like BSL-3, to study the acute phase of SARS-CoV-2 infection."

- Anthony Tanoto Tan, Ph.D., Senior Research Fellow, Duke-NUS Medical School, Singapore

COVID-19 Research Publications Using Ella

Simple Plex COVID-19 Cytokine Storm Panel

Measure key inflammation markers that are indicative of pathologic inflammatory response with a high-quality multianalyte assay. The 16x4 COVID-19 Cytokine Storm Panel is perfect for batching small numbers of samples and getting results fast. Learn more about the multianalyte cartridge.

COVID-19 Cytokine Storm Panel Markers
IL-1-beta IL-6 2nd Gen IL-8 TNF alpha 2nd Gen
Cytokine Storm Multianalyte Cartridge

Simple Plex Cytokine Screening Panel

The 32x8 Multiplex Cytokine Screening Panel gives you deep insight into an immunological response across a spectrum of critical markers. Get up to 256 results in just 90 minutes. Learn more about the multiplex cartridge.

Inflammatory Cytokine Panel Multiplex

In response to the global COVID-19 pandemic, the COVID-19 Cytokine Storm Panel and Multiplex Cytokine Screening Panel are available off the shelf and at a special discount. Off-the-shelf cartridges ship within 48 hours in the continental US.

DISCLAIMER:  The Ella™ automated immunoassay platform is currently offered For Research Use Only;  Not for Use in Diagnostic Procedures.

Bio-Techne's Tools for Coronavirus Research

As a leading company in the life sciences research sector, Bio-Techne develops products and resources to support coronavirus research, including reagents and platforms for SARS-CoV-2 detection, cytokine monitoring, and drug discovery. These tools help the scientific community better understand the mechanisms of infection and develop effective treatments. Learn more about Bio-Techne's portfolio or products for Coronavirus Research.

Explore More COVID-19 Research Tools

COVID-19 Research

 

Simple Plex Applications

COVID-19

COVID-19 Research Multiplex Assays

Inflammation

Inflammation Research Assays

Cancer

Cancer Research Multiplex Assays

Neuroscience

Neuroscience Research Multiplex Assays

 

Cell Therapy

Cell Therapy Research Multiplex Assays

Bioprocess Dev.

Bioprocess Development Multiplex Assays
 
 
Other Simple Plex Products

Single Plex

Single Plex cartridge

Multianalyte

Multianalyte cartridge

Multiplex

Multiplex cartridge

Customizable

Customizable cartridge